RSV 2022 Session 1A: How to Sustain Opioid Settlement Funding (Day 1)

The opioid settlement is a significant opportunity to improve substance use disorder prevention, treatment, and recovery. By attending to the evidence base and leveraging other funding sources, we can transform our behavioral health system to work better for people with substance use disorder. The Steadman Group related their experience in facilitating opioid settlement governance so you can optimize your settlement spending!

Presenter(s):

• J. K. Costello, MD, MPH, Director of Behavioral Health Consulting, The Steadman Group
• Lindsay Houston, MPH, Behavioral Health Consultant, The Steadman Group

These resources may not be Section 508-compliant. If you have an immediate need for a Section 508-compliant resource, please contact RCORP-TA-RSV@jbsinternational.com.